MSB 4.61% $1.40 mesoblast limited

"However, have they trialed enough patients to prove efficacy?...

  1. 7,594 Posts.
    lightbulb Created with Sketch. 826
    "However, have they trialed enough patients to prove efficacy? Could some of the statisticians comment on this?"

    By the way, it's 'trialled', not 'trialed'
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.